Compare Extra Space Storage, Inc. (EXR) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs Novavax Inc — how do they compare? Extra Space Storage, Inc. trades at $134.5 (market cap $28.12B), while Novavax Inc trades at $12.74 (market cap $1.82B). The key difference: Extra Space Storage, Inc. is far larger — about 15.5× Novavax Inc's market cap, and Extra Space Storage, Inc. pays a 4.87% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and Novavax Inc for 59 Days on average.
| EXR | NVAX | |
|---|---|---|
Market Cap | $28.12B | $1.82B |
Volume | 2,595,579 | 6,198,505 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $12.56 |
52-Week Low | $126.67 | $6.22 |
Typical Hold Time | 109 Days | 59 Days |
Enterprise Value | $41.84B | $1.39B |
Dividend Yield | 4.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXR trades at $134.65, up 2.24% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38B in 2025, and net income margin stands at 27.79%. Analyst consensus is split evenly between Buy and Hold, with a price target of $158.33. Recent news highlights leadership transition and dividend declarations.
Outlook is balanced: solid operational performance and dividend yield support the stock, but high valuation ratios and bearish technicals pose near-term risks. Investors should weigh strong fundamentals against potential volatility from interest rate sensitivity and market sentiment shifts.
Novavax (NVAX) trades at $12.75, up 13.64% with strong technical momentum and bullish moving averages. The company shows mixed fundamentals with revenue of $1.12B in 2025 and positive net income of $440.30M, though 2026 projections indicate a return to losses. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivot toward Matrix-M adjuvant licensing partnerships.
The outlook remains speculative with high volatility. Opportunities include partnership-driven growth and vaccine demand, but risks involve consistent profitability challenges, high debt-to-asset ratios, and competitive pressures. Analyst sentiment is predominantly bullish (73.9% buy ratings), yet investors should weigh the company's transition phase against financial stability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
